Menu
ÚHKT

Impaktované publikace

[21]

Šálek, C.; Folber, F.; Froňková, E.; Procházka, B.; Marinov, I.; Cetkovský, P.; Mayer, J.; Doubek, M.

Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia

[rok vydání 2015, impact factor 2.653 ]

[22]

Zavoral, M.; Minarikova, P.; Zavada, F.; Salek, C.; Minarik, M.

Molecular biology of pancreatic cancer

[rok vydání 2011, impact factor 2.471 ]

[23]

Vydra, J.; Válková, V.; Čemusová, B.; Kolář, M.; Nováková, L.; Soukup, P.; Šálek, C.; Vraná, M.; Pytlík, R.; Lesný, P.; Vítek, A.; Cetkovský, P.; Marková, M.

Hematopoietic stem cell transplantation from haploidentical donors in aplasia after cladribine/cytarabine chemotherapy for refractory acute myeloid leukemia or myelodysplastic syndrome

[rok vydání 2019, impact factor 2.298 ]

[24]

Hrabovsky, S.; Folber, F.; Horacek, J.M.; Stehlikova, O.; Jelinkova, H.; Salek, C.; Doubek, M.

Comparison of real-time quantitative polymerase chain reaction and eight-color flow cytometry in assessment of minimal residual disease in adult acute lymphoblastic leukemia

[rok vydání 2018, impact factor 2.274 ]

[25]

Vydra, J.; Šálek, C.; Schwarz, J.; Žák, P.; Novák, J.; Petečuková, V.; Pecherková, P.; Mayer, J.; Cetkovský, P.; Ráčil, Z.

Analysis of real-world data on postremission therapy for acute myeloid leukemia with intermediate risk cytogenetics in first complete remission

[rok vydání 2017, impact factor 2.274 ]

[26]

Sarova, I.; Brezinova, J.; Zemanova, Z.; Ransdorfova, S.; Svobodova, K.; Izakova, S.; Pavlistova, L.; Lizcova, L.; Berkova, A.; Skipalova, K.; Hodanova, L.; Salek, C.; Jonasova, A.; Michalova, K.

High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype

[rok vydání 2018, impact factor 2.066 ]

[27]

Holicek, P.; Truxova, I.; Kasikova, L.; Vosahlikova, S.; Salek, C.; et al.

Assessment of NK cell-mediated cytotoxicity by flow cytometry after rapid, high-yield isolation from peripheral blood

[rok vydání 2019, impact factor 1.600 ]

[28]

Válková, V.; Polák, J.; Marková, M.; Vítek, A.; Hájková, H.; Šálek, C.; Procházka, B.; Cetkovský, P.; Trněný, M.

Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis

[rok vydání 2012, impact factor 1.486 ]

[29]

Polák, J.; Hájková, H.; Maaloufová-Soukupová, J.; Marková, J.; Šálek, C.; Schwarz, J.; Haškovec, C.

Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression

[rok vydání 2011, impact factor 0.344 ]